Marina V.
Marina V. Busuek, Center Valley, PA US
Patent application number | Description | Published |
---|---|---|
20140135485 | 6-11 BICYCLIC KETOLIDE DERIVATIVES - The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof: | 05-15-2014 |
Marina V. Chuenkova, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20120245221 | ANTI-APOPTOTIC AGENTS AND USES THEREOF - The invention generally relates to the use of parasite-derived neurotrophic factor (PDNF), or a fragment of PDNF, to reduce cell apoptosis. The PDNF or PDNF fragment is provided in the cytoplasm of a cell so that it can bind to Akt kinase and induce Akt kinase activation. | 09-27-2012 |
Marina V. Demcheva, Tewksbury, MA US
Patent application number | Description | Published |
---|---|---|
20130287853 | COMPOSITIONS AND METHODS FOR NANOPOLYMER-BASED NUCLEIC ACID DELIVERY - Provided herein are p-GlcNAc nanoparticle/nucleic acid compositions. In one aspect, the p-GlcNAc nanoparticle/nucleic acid compositions comprise deacetylated poly-N-acetylglucosamine lactate derivative nanoparticles less than 500 nm and a nucleic acid. Also, provided herein are methods for administering a nucleic acid to a subject, the method comprising administering to the subject a p-GlcNAc nanoparticle/nucleic acid composition. In certain embodiments, the p-GlcNAc nanoparticle/nucleic acid composition is administered subcutaneously to the subject. | 10-31-2013 |
Marina V. Nasonova, Kemerovo RU
Patent application number | Description | Published |
---|---|---|
20160045643 | Method for Making Biodegradable Anti-Adhesion Membranes for Cardiac Surgery - A method for the manufacture of biodegradable membranes for preventing adhesion formation followed open heart surgery is described herein. The manufacturing of biodegradable membranes is based on polymeric composition, comprised of copolymer of polyhydroxybutyrate/hydroxyvalerate (PHBV), poly(D,L-lactide) in the ratio of the dried powders of 3:1, the resulting mixture is dissolved in chloroform to a concentration of 6-9% followed by thorough mixing for 2 hours and heating up to 35° C. The membrane is produced by electrostatic spinning (electrospinning), wherein biologically active substances from fibrinolytic agents or direct anticoagulants are embedded in the structure of the fiber. | 02-18-2016 |
Marina V. Pryzhkova US
Patent application number | Description | Published |
---|---|---|
20120184466 | PARTHENOGENIC ACTIVATION OF HUMAN OOCYTES FOR THE PRODUCTION OF HUMAN EMBRYONIC STEM CELLS - Methods of producing human stem cells are disclosed for parthenogenetically activating human oocytes by manipulation of O | 07-19-2012 |
Marina V. Pryzhkova, Moscow RU
Patent application number | Description | Published |
---|---|---|
20100233143 | Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells - Methods of producing human stem cells are disclosed for parthenogenetically activating human oocytes by manipulation of O | 09-16-2010 |
20100248989 | Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells - Methods of producing human stem cells are disclosed for parthenogenetically activating human oocytes by manipulation of O | 09-30-2010 |
Marina V. Zalevskaya, Redmond, WA US
Patent application number | Description | Published |
---|---|---|
20100324745 | Method for estimating generation limits - Method is provided for estimating generation limits. | 12-23-2010 |